Intriguingly, Uro-A (23.92 μM) decreased the phosphorylation state of p-Akt and ERK 1/2 in the UMUC3 cell line, suggesting that Uro-A could serve as a potential therapeutic agent for bladder cancer (20). The gene discussed is AKT1; the disease is urinary bladder cancer.